English
简体中文
Total: £ 56.28
Published Date: 2025-10-08 | Pages: 139 | Tables: 148 | Medical Devices & Consumables
The global Tube Insulin Pumps market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Tube insulin pumps are medical devices used by individuals with diabetes to deliver insulin continuously throughout the day. These pumps consist of a small external device connected to the body via a thin tube (cannula), which delivers insulin into the subcutaneous tissue. The user can program the pump to release specific amounts of insulin to manage blood sugar levels, replacing the need for multiple daily injections. This system allows for more precise and flexible insulin management, improving the quality of life for people with diabetes.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Tube Insulin Pumps leading manufacturers including Medtronic, Tandem, SOOIL, Fornia, Phray, Apex Medical, Ypsomed, MedNovo, etc., dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Tube Insulin Pumps market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Medtronic
Tandem
SOOIL
Fornia
Phray
Apex Medical
Ypsomed
MedNovo
Segment by Type
Intelligent Pump
Non-intelligent Pump
Segment by Application
Hospitals
Homecare
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Tube Insulin Pumps study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Tube Insulin Pumps: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Tube Insulin Pumps Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Intelligent Pump
1.2.3 Non-intelligent Pump
1.3 Market Segmentation by Application
1.3.1 Global Tube Insulin Pumps Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Homecare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tube Insulin Pumps Revenue Estimates and Forecasts 2020-2031
2.2 Global Tube Insulin Pumps Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Tube Insulin Pumps Sales Estimates and Forecasts 2020-2031
2.4 Global Tube Insulin Pumps Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Tube Insulin Pumps Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Tube Insulin Pumps Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Intelligent Pump Market Size by Manufacturers
3.5.2 Non-intelligent Pump Market Size by Manufacturers
3.6 Global Tube Insulin Pumps Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Tube Insulin Pumps Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Tube Insulin Pumps Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Tube Insulin Pumps Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Tube Insulin Pumps Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Tube Insulin Pumps Sales and Revenue by Type (2020-2031)
6.4 North America Tube Insulin Pumps Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Tube Insulin Pumps Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Tube Insulin Pumps Sales and Revenue by Type (2020-2031)
7.4 Europe Tube Insulin Pumps Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Tube Insulin Pumps Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Tube Insulin Pumps Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Tube Insulin Pumps Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Tube Insulin Pumps Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Tube Insulin Pumps Sales and Revenue by Type (2020-2031)
9.4 Central and South America Tube Insulin Pumps Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Tube Insulin Pumps Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Tube Insulin Pumps Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Tube Insulin Pumps Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Tube Insulin Pumps Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Tube Insulin Pumps Product Models, Descriptions and Specifications
11.1.4 Medtronic Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Tube Insulin Pumps Sales by Product in 2024
11.1.6 Medtronic Tube Insulin Pumps Sales by Application in 2024
11.1.7 Medtronic Tube Insulin Pumps Sales by Geographic Area in 2024
11.1.8 Medtronic Tube Insulin Pumps SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Tandem
11.2.1 Tandem Corporation Information
11.2.2 Tandem Business Overview
11.2.3 Tandem Tube Insulin Pumps Product Models, Descriptions and Specifications
11.2.4 Tandem Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Tandem Tube Insulin Pumps Sales by Product in 2024
11.2.6 Tandem Tube Insulin Pumps Sales by Application in 2024
11.2.7 Tandem Tube Insulin Pumps Sales by Geographic Area in 2024
11.2.8 Tandem Tube Insulin Pumps SWOT Analysis
11.2.9 Tandem Recent Developments
11.3 SOOIL
11.3.1 SOOIL Corporation Information
11.3.2 SOOIL Business Overview
11.3.3 SOOIL Tube Insulin Pumps Product Models, Descriptions and Specifications
11.3.4 SOOIL Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 SOOIL Tube Insulin Pumps Sales by Product in 2024
11.3.6 SOOIL Tube Insulin Pumps Sales by Application in 2024
11.3.7 SOOIL Tube Insulin Pumps Sales by Geographic Area in 2024
11.3.8 SOOIL Tube Insulin Pumps SWOT Analysis
11.3.9 SOOIL Recent Developments
11.4 Fornia
11.4.1 Fornia Corporation Information
11.4.2 Fornia Business Overview
11.4.3 Fornia Tube Insulin Pumps Product Models, Descriptions and Specifications
11.4.4 Fornia Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Fornia Tube Insulin Pumps Sales by Product in 2024
11.4.6 Fornia Tube Insulin Pumps Sales by Application in 2024
11.4.7 Fornia Tube Insulin Pumps Sales by Geographic Area in 2024
11.4.8 Fornia Tube Insulin Pumps SWOT Analysis
11.4.9 Fornia Recent Developments
11.5 Phray
11.5.1 Phray Corporation Information
11.5.2 Phray Business Overview
11.5.3 Phray Tube Insulin Pumps Product Models, Descriptions and Specifications
11.5.4 Phray Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Phray Tube Insulin Pumps Sales by Product in 2024
11.5.6 Phray Tube Insulin Pumps Sales by Application in 2024
11.5.7 Phray Tube Insulin Pumps Sales by Geographic Area in 2024
11.5.8 Phray Tube Insulin Pumps SWOT Analysis
11.5.9 Phray Recent Developments
11.6 Apex Medical
11.6.1 Apex Medical Corporation Information
11.6.2 Apex Medical Business Overview
11.6.3 Apex Medical Tube Insulin Pumps Product Models, Descriptions and Specifications
11.6.4 Apex Medical Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Apex Medical Recent Developments
11.7 Ypsomed
11.7.1 Ypsomed Corporation Information
11.7.2 Ypsomed Business Overview
11.7.3 Ypsomed Tube Insulin Pumps Product Models, Descriptions and Specifications
11.7.4 Ypsomed Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Ypsomed Recent Developments
11.8 MedNovo
11.8.1 MedNovo Corporation Information
11.8.2 MedNovo Business Overview
11.8.3 MedNovo Tube Insulin Pumps Product Models, Descriptions and Specifications
11.8.4 MedNovo Tube Insulin Pumps Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MedNovo Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Tube Insulin Pumps Industry Chain
12.2 Tube Insulin Pumps Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Tube Insulin Pumps Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Tube Insulin Pumps Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Tube Insulin Pumps Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Tube Insulin Pumps Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Tube Insulin Pumps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Tube Insulin Pumps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Tube Insulin Pumps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Tube Insulin Pumps Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Tube Insulin Pumps Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Tube Insulin Pumps Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Tube Insulin Pumps Sales by Region (2020-2025) & (Units)
Table 8. Global Tube Insulin Pumps Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Tube Insulin Pumps Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Tube Insulin Pumps Sales Share by Manufacturers (2020-2025)
Table 12. Global Tube Insulin Pumps Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Tube Insulin Pumps Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Tube Insulin Pumps by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tube Insulin Pumps as of 2024)
Table 16. Global Tube Insulin Pumps Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Tube Insulin Pumps Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Tube Insulin Pumps Manufacturing Base and Headquarters
Table 19. Global Tube Insulin Pumps Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Tube Insulin Pumps Sales by Type (2020-2025) & (Units)
Table 23. Global Tube Insulin Pumps Sales by Type (2026-2031) & (Units)
Table 24. Global Tube Insulin Pumps Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Tube Insulin Pumps Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Tube Insulin Pumps ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Tube Insulin Pumps Sales by Application (2020-2025) & (Units)
Table 29. Global Tube Insulin Pumps Sales by Application (2026-2031) & (Units)
Table 30. Tube Insulin Pumps High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Tube Insulin Pumps Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Tube Insulin Pumps Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Tube Insulin Pumps ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Tube Insulin Pumps Growth Accelerators and Market Barriers
Table 37. North America Tube Insulin Pumps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Tube Insulin Pumps Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Tube Insulin Pumps Growth Accelerators and Market Barriers
Table 40. Europe Tube Insulin Pumps Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Tube Insulin Pumps Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Tube Insulin Pumps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Tube Insulin Pumps Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Tube Insulin Pumps Growth Accelerators and Market Barriers
Table 45. Southeast Asia Tube Insulin Pumps Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Tube Insulin Pumps Investment Opportunities and Key Challenges
Table 47. Central and South America Tube Insulin Pumps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Tube Insulin Pumps Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Tube Insulin Pumps Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Medtronic Corporation Information
Table 51. Medtronic Description and Major Businesses
Table 52. Medtronic Product Models, Descriptions and Specifications
Table 53. Medtronic Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Medtronic Sales Value Proportion by Product in 2024
Table 55. Medtronic Sales Value Proportion by Application in 2024
Table 56. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 57. Medtronic Tube Insulin Pumps SWOT Analysis
Table 58. Medtronic Recent Developments
Table 59. Tandem Corporation Information
Table 60. Tandem Description and Major Businesses
Table 61. Tandem Product Models, Descriptions and Specifications
Table 62. Tandem Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Tandem Sales Value Proportion by Product in 2024
Table 64. Tandem Sales Value Proportion by Application in 2024
Table 65. Tandem Sales Value Proportion by Geographic Area in 2024
Table 66. Tandem Tube Insulin Pumps SWOT Analysis
Table 67. Tandem Recent Developments
Table 68. SOOIL Corporation Information
Table 69. SOOIL Description and Major Businesses
Table 70. SOOIL Product Models, Descriptions and Specifications
Table 71. SOOIL Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. SOOIL Sales Value Proportion by Product in 2024
Table 73. SOOIL Sales Value Proportion by Application in 2024
Table 74. SOOIL Sales Value Proportion by Geographic Area in 2024
Table 75. SOOIL Tube Insulin Pumps SWOT Analysis
Table 76. SOOIL Recent Developments
Table 77. Fornia Corporation Information
Table 78. Fornia Description and Major Businesses
Table 79. Fornia Product Models, Descriptions and Specifications
Table 80. Fornia Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Fornia Sales Value Proportion by Product in 2024
Table 82. Fornia Sales Value Proportion by Application in 2024
Table 83. Fornia Sales Value Proportion by Geographic Area in 2024
Table 84. Fornia Tube Insulin Pumps SWOT Analysis
Table 85. Fornia Recent Developments
Table 86. Phray Corporation Information
Table 87. Phray Description and Major Businesses
Table 88. Phray Product Models, Descriptions and Specifications
Table 89. Phray Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Phray Sales Value Proportion by Product in 2024
Table 91. Phray Sales Value Proportion by Application in 2024
Table 92. Phray Sales Value Proportion by Geographic Area in 2024
Table 93. Phray Tube Insulin Pumps SWOT Analysis
Table 94. Phray Recent Developments
Table 95. Apex Medical Corporation Information
Table 96. Apex Medical Description and Major Businesses
Table 97. Apex Medical Product Models, Descriptions and Specifications
Table 98. Apex Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Apex Medical Recent Developments
Table 100. Ypsomed Corporation Information
Table 101. Ypsomed Description and Major Businesses
Table 102. Ypsomed Product Models, Descriptions and Specifications
Table 103. Ypsomed Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Ypsomed Recent Developments
Table 105. MedNovo Corporation Information
Table 106. MedNovo Description and Major Businesses
Table 107. MedNovo Product Models, Descriptions and Specifications
Table 108. MedNovo Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. MedNovo Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Tube Insulin Pumps Product Picture
Figure 2. Global Tube Insulin Pumps Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Intelligent Pump Product Picture
Figure 4. Non-intelligent Pump Product Picture
Figure 5. Global Tube Insulin Pumps Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospitals
Figure 7. Homecare
Figure 8. Tube Insulin Pumps Report Years Considered
Figure 9. Global Tube Insulin Pumps Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 11. Global Tube Insulin Pumps Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Tube Insulin Pumps Revenue Market Share by Region (2020-2031)
Figure 13. Global Tube Insulin Pumps Sales (2020-2031) & (Units)
Figure 14. Global Tube Insulin Pumps Sales (CAGR) by Region (2020-2031) (Units)
Figure 15. Global Tube Insulin Pumps Sales Market Share by Region (2020-2031)
Figure 16. Top 5 and Top 10 Manufacturers Tube Insulin Pumps Sales Volume Market Share in 2024
Figure 17. Global Tube Insulin Pumps Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Intelligent Pump Revenue Market Share by Manufacturer in 2024
Figure 20. Non-intelligent Pump Revenue Market Share by Manufacturer in 2024
Figure 21. Global Tube Insulin Pumps Sales Market Share by Type (2020-2031)
Figure 22. Global Tube Insulin Pumps Revenue Market Share by Type (2020-2031)
Figure 23. Global Tube Insulin Pumps Sales Market Share by Application (2020-2031)
Figure 24. Global Tube Insulin Pumps Revenue Market Share by Application (2020-2031)
Figure 25. North America Tube Insulin Pumps Sales YoY (2020-2031) & (Units)
Figure 26. North America Tube Insulin Pumps Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Manufacturers Tube Insulin Pumps Sales Revenue (US$ Million) in 2024
Figure 28. North America Tube Insulin Pumps Sales Volume (Units) by Type (2020- 2031)
Figure 29. North America Tube Insulin Pumps Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 30. North America Tube Insulin Pumps Sales Volume (Units) by Application (2020-2031)
Figure 31. North America Tube Insulin Pumps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 32. US Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 33. Canada Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 34. Mexico Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 35. Europe Tube Insulin Pumps Sales YoY (2020-2031) & (Units)
Figure 36. Europe Tube Insulin Pumps Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Europe Top 5 Manufacturers Tube Insulin Pumps Sales Revenue (US$ Million) in 2024
Figure 38. Europe Tube Insulin Pumps Sales Volume (Units) by Type (2020-2031)
Figure 39. Europe Tube Insulin Pumps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Tube Insulin Pumps Sales Volume (Units) by Application (2020-2031)
Figure 41. Europe Tube Insulin Pumps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. Germany Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 43. France Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 44. U.K. Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 45. Italy Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 46. Russia Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Tube Insulin Pumps Sales YoY (2020-2031) & (Units)
Figure 48. Asia-Pacific Tube Insulin Pumps Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Top 8 Manufacturers Tube Insulin Pumps Sales Revenue (US$ Million) in 2024
Figure 50. Asia-Pacific Tube Insulin Pumps Sales Volume (Units) by Type (2020- 2031)
Figure 51. Asia-Pacific Tube Insulin Pumps Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 52. Asia-Pacific Tube Insulin Pumps Sales Volume (Units) by Application (2020-2031)
Figure 53. Asia-Pacific Tube Insulin Pumps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Indonesia Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 55. Japan Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 56. South Korea Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 57. China Taiwan Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 58. India Tube Insulin Pumps Revenue (2020-2031) & (US$ Million)
Figure 59. Central and South America Tube Insulin Pumps Sales YoY (2020-2031) & (Units)
Figure 60. Central and South America Tube Insulin Pumps Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Manufacturers Tube Insulin Pumps Sales Revenue (US$ Million) in 2024
Figure 62. Central and South America Tube Insulin Pumps Sales Volume (Units) by Type (2021-2031)
Figure 63. Central and South America Tube Insulin Pumps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 64. Central and South America Tube Insulin Pumps Sales Volume (Units) by Application (2020-2031)
Figure 65. Central and South America Tube Insulin Pumps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Brazil Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 67. Argentina Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 68. Middle East, and Africa Tube Insulin Pumps Sales YoY (2020-2031) & (Units)
Figure 69. Middle East and Africa Tube Insulin Pumps Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Manufacturers Tube Insulin Pumps Sales Revenue (US$ Million) in 2024
Figure 71. Middle East and Africa Tube Insulin Pumps Sales Volume (Units) by Type (2021-2031)
Figure 72. South America Tube Insulin Pumps Sales Revenue (US$ Million) by Type (2020-2031)
Figure 73. Middle East and Africa Tube Insulin Pumps Sales Volume (Units) by Application (2020-2031)
Figure 74. Middle East and Africa Tube Insulin Pumps Sales Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 76. Turkey Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa Tube Insulin Pumps Revenue (2020-2025) & (US$ Million)
Figure 79. Tube Insulin Pumps Industry Chain Mapping
Figure 80. Regional Tube Insulin Pumps Manufacturing Base Distribution (%)
Figure 81. Global Tube Insulin Pumps Production Market Share by Region (2020-2031)
Figure 82. Tube Insulin Pumps Production Process
Figure 83. Regional Tube Insulin Pumps Production Cost Structure
Figure 84. Channels of Distribution (Direct Vs Distribution)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
